deltatrials
Suspended PHASE1 INTERVENTIONAL 1-arm NCT01974479

Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia

Sponsor: National University Health System, Singapore

Conditions B-cell Acute Lymphoblastic Leukemia
Interventions anti-CD19 redirected NK cells
Updated 10 times since 2017 Last updated: Apr 10, 2019 Started: Sep 30, 2013 Primary completion: Feb 28, 2017 Completion: Feb 29, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Suspended for an interim review of (CAR) CD19 research strategy for the treatment of CD19 positive ALL.

Listed as NCT01974479, this PHASE1 trial focuses on B-cell Acute Lymphoblastic Leukemia and remains suspended. Sponsored by National University Health System, Singapore, it has been updated 10 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotRecruiting~Sep 2017 – ~May 2018 · 8 months · monthly snapshotSuspended~May 2018 – ~Jun 2018 · 31 days · monthly snapshotSuspended~Jun 2018 – ~May 2019 · 11 months · monthly snapshotSuspended~May 2019 – ~Nov 2020 · 18 months · monthly snapshotSuspended~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotSuspended~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotSuspended~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotSuspended~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotSuspended~Sep 2024 – present · 22 months · monthly snapshotSuspended

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Suspended PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Suspended PHASE1

  3. Dec 2021 — Jul 2024 [monthly]

    Suspended PHASE1

  4. Jan 2021 — Dec 2021 [monthly]

    Suspended PHASE1

  5. Nov 2020 — Jan 2021 [monthly]

    Suspended PHASE1

▶ Show 5 earlier versions

  1. May 2019 — Nov 2020 [monthly]

    Suspended PHASE1

  2. Jun 2018 — May 2019 [monthly]

    Suspended PHASE1

  3. May 2018 — Jun 2018 [monthly]

    Suspended PHASE1

  4. Sep 2017 — May 2018 [monthly]

    Suspended PHASE1

    Status: Recruiting → Suspended · Phase: PHASE2 → PHASE1

  5. Jan 2017 — Sep 2017 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National University Health System, Singapore
Data source: National University Health System, Singapore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations